Inicio › Cáncer de próstata › Virginia › Charlottesville
Ensayos clínicos de Cáncer de próstata en Charlottesville, VA
15 estudios para Cáncer de próstata buscan participantes en centros de Charlottesville y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ReclutandoFase 3
- University of Virginia Health System ( Site 0054), Charlottesville
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
ReclutandoFase 3
- University of Virginia Comprehensive Cancer Center, Charlottesville
- University of Virginia, Charlottesville
- UVA Health Cancer Care Pantops, Charlottesville
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
ReclutandoFase 3
- University of Virginia Cancer Center, Charlottesville
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
ReclutandoFase 2
- University of Virginia Cancer Center, Charlottesville
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Sentara Martha Jefferson Hospital, Charlottesville
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutandoFase 3
- University of Virginia Cancer Center, Charlottesville
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ReclutandoFase 2
- University of Virginia Comprehensive Cancer Center, Charlottesville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Virginia, Charlottesville
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- University of Virginia Cancer Center, Charlottesville
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
ReclutandoFase 1/2
- University of Virginia, Charlottesville
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
Reclutando
- University of Virginia Health System, Charlottesville
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
ReclutandoEstudio observacional
- University of Virginia, Charlottesville
Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
Reclutando
- University of Virginia, Charlottesville
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
ReclutandoFase 1
- University of Virginia Cancer Center, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Charlottesville
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY103 estudios
- Houston, TX76 estudios
- Los Angeles, CA61 estudios
- Boston, MA59 estudios
- St. Louis, MO46 estudios
- Chicago, IL45 estudios
- San Francisco, CA45 estudios
- Philadelphia, PA44 estudios
- Baltimore, MD43 estudios
- Nashville, TN42 estudios
- Seattle, WA42 estudios
- Washington, DC38 estudios
Otros estudios en Charlottesville
- Cáncer de pulmón de células no pequeñas21 estudios
- Leucemia mielógena aguda16 estudios
- Cáncer metastásico13 estudios
- Cáncer de endometrio13 estudios
- Cáncer (todos los tipos)13 estudios
- Cáncer de pulmón13 estudios
- Fallo cardíaco11 estudios
- Cáncer de ovario10 estudios
- Cáncer del colon y del recto10 estudios
- Diabetes tipo 19 estudios
- Cáncer de seno9 estudios
- Cáncer de páncreas9 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.